Correlation Between Hillstream Biopharma and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and SAB Biotherapeutics, you can compare the effects of market volatilities on Hillstream Biopharma and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and SAB Biotherapeutics.
Diversification Opportunities for Hillstream Biopharma and SAB Biotherapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Hillstream and SAB is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Hillstream Biopharma and SAB Biotherapeutics
Given the investment horizon of 90 days Hillstream Biopharma is expected to generate 18.19 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Hillstream Biopharma is 8.56 times less risky than SAB Biotherapeutics. It trades about 0.05 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 6.40 in SAB Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 0.43 from holding SAB Biotherapeutics or generate 6.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 41.44% |
| Values | Daily Returns |
Hillstream Biopharma vs. SAB Biotherapeutics
Performance |
| Timeline |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| SAB Biotherapeutics |
Hillstream Biopharma and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hillstream Biopharma and SAB Biotherapeutics
The main advantage of trading using opposite Hillstream Biopharma and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |